| | 55937-99-0 Basic information More.. |
| Product Name: | Beclobrate | | Synonyms: | Beclobrate;Beclipur;Ethyl(±)-2-[[α(-(4-chlorophenyl)-4-tolyl]oxy]-2-methylbutyrate;Sgd-24774;Turec;2-[4-(4-Chlorobenzyl)phenoxy]-2-methylbutyric acid ethyl ester;Butanoic acid, 2-[4-[(4-chlorophenyl)Methyl]phenoxy]-2-Methyl-, ethyl ester;Ethyl 2-(4-(4-chlorobenzyl)phenoxy)-2-Methylbutanoate | | CAS: | 55937-99-0 | | MF: | C20H23ClO3 | | MW: | 346.85 | | EINECS: | 259-912-4 | | Mol File: | 55937-99-0.mol |  |
Use
Beclobrate, an antihyperlipidaemic agent, was introduced into
medicine in 1985. Although a causal relationship between the use of the drug and
hepatic toxicity has not been established, the Intercantonal Office for the Control of
Medicines has withdrawn marketing authorization since safer therapeutic
alternatives are available. Beclobrate is not registered elsewhere.
- Beclobrate
-
- US $293.00-987.00 / mg
- 2025-07-10
- CAS:55937-99-0
- Min. Order:
- Purity: 99.41%
- Supply Ability: 10g
- Beclobrate
-
- US $0.00-0.00 / KG
- 2020-05-12
- CAS:55937-99-0
- Min. Order: 1KG
- Purity: 99.0%
- Supply Ability: 500 MT
|
|
55937-99-0
Recommend Suppliers |
|